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Making the business case for an addiction
medicine consult service: a qualitative
analysis
Kelsey C. Priest1,2* and Dennis McCarty2,3
Abstract
Background: As the drug poisoning crisis worsens in North America and opioid use disorder (OUD)-related
hospital admissions increase, policymakers and hospital administrators are beginning to recognize the important
role of hospitals in the OUD care continuum. This study explores and describes how U.S. addiction medicine
physicians created and presented business propositions to hospital administrators to support the development of
addiction medicine consult (AMC) services.
Methods: Fifteen qualitative interviews were completed with board-certified or board-eligible addiction medicine
physicians from 14 U.S. hospitals. The interviews occurred as part of a broader mixed methods study exploring
hospital service delivery for patients admitted with OUD. Using a directed content analysis, the transcribed
interviews were coded, analyzed, and final themes consolidated.
Results: Semi-structured interviews completed with addiction medicine physicians from established (n = 9) and
developing (n = 5) AMC services at 14 U.S. hospitals explored how clinical champions persuaded hospital
administrators to support AMC service development. Four elements were foundational to making the “business
case”: 1) describing the prevalence of substance use disorder (SUD) or OUD in the hospital; 2) identifying the
negative financial impacts of not treating SUDs during hospitalization; 3) highlighting the ongoing care quality and
treatment gap for hospitalized patients with SUDs; and 4) noting the success of other institutional AMC services.
Study findings informed the creation of tools to support AMC service development: 1) an AMC service business
case template, and 2) an AMC service design and operations resource list.
Conclusions: OUD-related hospital admissions are unlikely to abate. Hospital administrators should consider
innovative care delivery mechanisms to improve care for persons with OUD. AMC services may be a promising
delivery mechanism to achieve this aim. For clinical and administrative champions, understanding how to
communicate the potential effectiveness of this intervention to hospital leaders is an essential first step to AMC
service creation.
Keywords: Opioid use disorder, Substance use disorder, Opioid agonist therapy, Buprenorphine/naloxone,
Methadone, Addiction medicine consult service, Addiction consult service, Consultation service, Hospital leadership,
Hospital management
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Background
The opioid-related overdose epidemic touches all facets of
the health care delivery system, particularly increased use
of acute care delivery services in emergency departments
and hospitals [1]. Opioid use disorder (OUD)-related hos-
pitalizations in the U.S. are estimated to cost $15 billion
annually [2]. Research suggests that patients hospitalized
with OUD may receive suboptimal care during admission
[3] and upon discharge [4, 5]. These findings likely reflect
the limitations in design, resources, and attention to ser-
vice delivery for patients with OUD and other substance
use disorder (SUDs) in the hospital.
Fortunately, effective interventions exist to treat and
manage OUD and other SUDs in the hospital. Interven-
tions for treating hospital-based OUD include: a) care de-
livery checklists [6–9]; b) initiating opioid agonist therapy
([OAT]—methadone and buprenorphine) [10, 11]; and c)
addiction medicine consult (AMC) services [12–20]. The
literature base describes the design, implementation, and
effectiveness of hospital AMC services. Most published
studies are single-site prospective evaluations [14, 16],
retrospective assessments [18, 19], or descriptive imple-
mentation case studies [12]. Research suggests that AMC
services are feasible from the perspective of the health sys-
tem [20] and the patient [15], that AMC services increase
the delivery of evidence-based care during hospitalization
[13, 14] and upon discharge [14], and improve patient re-
lated addiction outcomes [16].
A narrative review summarized AMC service delivery
attributes and the consultation process, specifically how to
identify patients, the service team composition, and con-
sultation components [21]. Little is known, however,
about AMC service design and operations, beyond single-
site descriptions. A qualitative analysis, based on a smaller
sample of this study cohort, compared the organizational
design of nine operational U.S. AMC services [17]. Gener-
ally, services in this study were staffed on the weekdays
but not weekends, had interprofessional team member
representation, had complex and uncertain financing, and
were responsible for three practice domains: 1) hospital
staff education on evidence-based SUD-related treatment;
2) delivery of psychosocial and medical services to patients
with SUDs; and 3) development of hospital SUD guidance
documents and policies [17]. An important facilitator
leading to AMC service establishment was the creation
and presentation of the service business case to hospital
administrators. The strategies used by clinical leaders to
make the business case for implementing AMC services
are examined in this analysis.
Methods
Research question and theoretical underpinnings
This analysis was part of a broader mixed methods
study, which asked the question: How do supply-side
attributes influence hospital OAT delivery, health out-
comes, and health services utilization for persons hospi-
talized with OUD? [22]. Supply-side attributes are the
contextual elements inside and outside of a hospital that
may be associated with hospital OAT delivery, such as
social structures (e.g., hospital standards of care) and re-
sources and technologies (e.g., hospital staffing, federal
treatment policies) [22]. The study’s broader conceptual
framework is described elsewhere [17, 22]; however, two
theoretical assumptions guided this sub-analysis: the ra-
tional actor model and institutional theory. In this study,
hospitals were assumed to behave as rational unitary
decision-makers [23, 24] to meet the needs of their
political and economic environments [25]. Institutional
theory asserts that the external environment shapes or-
ganizations through a process called isomorphism which
drives organizations towards homogeneity through coer-
cion, mimicry, and normative behaviors of external
stakeholders [26]. These assumptions suggest that hos-
pital leaders choosing to implement an AMC service do
so because they believe that the service is a value-
maximizing activity for the hospital and that they are
influenced by external policies and organizations, includ-
ing other hospitals.
Recruitment and study cohort
A publicly available list of addiction medicine fellowship
programs served as the primary recruitment source [27].
Using a two-wave purposive sample technique, 45 po-
tential key informants received email invitations to
complete an interview on the topic of hospital-based ser-
vices for patients with OUD and SUD. Recommenda-
tions from dissertation mentors and respondent-driven
recommendations supplemented the study sample. The
final, and broader dissertation study cohort included 17
key informants from 16 U.S. hospitals. The findings pre-
sented below are an analysis of the interviews from a
sub-cohort (15 key informants, 14 U.S. hospitals) with
established or soon to be established AMC services. The
two interviews excluded from this analysis were from
hospitals without an AMC service or plans to start one.
Additional details on study sampling approach are avail-
able elsewhere [17, 22].
Study tools and data collection
During the 45-to-60-min interview participants completed
a short demographic survey (e.g., “What health professional
degree(s) do you have?”) (see Additional file 1) and an-
swered open-ended questions which probed for under-
standing of environmental and hospital supply-side
attributes: “What sorts of elements within your
organization supported the start of the consult ser-
vice?” (see Additional file 2). Oregon Health & Science
University’s Institutional Review Board reviewed and
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approved the study protocol and authorized the use of
an information sheet rather than a formal consent
process (IRB #18092). All participants gave their con-
sent to participate in this study. The interviews were
electronically recorded and transcribed. The interview
guide, and demographic survey were created as tools
used for a broader mixed methods study. Additional
details on study tools and data collection are available
elsewhere [17, 22].
Analysis
A directed content analysis approach [28] informed the
iterative transcript coding process. Qualitative analysis
software (Dedoose) managed the analytic process [29].
An interdisciplinary review of policy, organizational be-
havior, systems science, economics, and health services
delivery scholarship guided the development of an initial
interview codebook prior to data collection [22]. The
original codebook’s 5 umbrella categories, with 23 codes
[22], were refined during the analytic process to reflect
emergent findings [28]. The final coding scheme in-
cluded eight umbrella categories and 59 codes [22]. A
dual-coder process was used—after the primary investi-
gator (KCP) completed coding, a second coder (DM)
reviewed the coded transcripts and the code book. Cod-
ing discrepancies were discussed and reconciled between
the two coders and the primary author consolidated final
themes. Additional analytic details are available else-
where [17, 22].
Results
Participant and hospital characteristics
Study participants from 14U.S. hospitals were board-
certified (n = 14) or board-eligible (n = 1) addiction medi-
cine physicians with family medicine, internal medicine, ob-
stetrics and gynecology, pediatrics, and psychiatry training.
The mean age was 47 years and the seven women and eight
men were predominantly white (n = 14) and Non-Hispanic
or Latino (n = 13). Hospitals were located in the West (n =
4), Mid-west (n = 3), Northeast (n = 4), and South (n = 3)
regions of the U.S. Over half of hospitals had affiliated or
onsite addiction related services (e.g., opioid treatment pro-
grams [OTP] and detoxification beds). Three hospitals had
OTPs and detoxification beds, two hospitals had only
OTPs, three hospitals had only detoxification beds, and six
hospitals had neither. Methadone and buprenorphine prod-
ucts for OUD treatment were on formulary at 13 of the 14
hospitals. Of the 14 hospitals in this study, nine had an
AMC service and five planned to start a service. See Table 1
for a summary of hospital characteristics by region and
available services.
The AMC service business case
Hospital administrator buy-in was an essential prelimin-
ary step for AMC service establishment. The reasons ad-
ministrators supported AMC services varied. Informants
reported that some administrators believed that SUDs
were public health and medical issues, others had clin-
ical experience in treating SUDs, but most hospital
leaders supported AMC service establishment because of
the “business case.” Our analysis of the business case ap-
proach includes a description of who was involved in its
creation (The Who), the content of the case (The Why),
and concludes with a business case template (Fig. 1) and
a resource list (Fig. 2) to support health care champions
who plan to start an AMC service.
The Who
Addiction medicine physicians were primarily respon-
sible for developing and presenting the AMC service
business case to hospital administrators to gain their
support:
Mainly me [an addiction medicine physician]
knocking on a lot of doors. Putting up a fuss. And
really just being a squeaky wheel.
And the reason the addiction service director, is the
director, is that she was very skilled at navigating that
conversation with hospital administration and
convincing key hospital administrators to put up
funding for this initially.
We had a few clinical champions saying ‘gee we can
help these people.’ We had a clinical environment in
which nursing staff and primary teams were really
overwhelmed and felt they had nothing to offer patients
with addiction issues. Patients were perceived as being
frequently disruptive, challenging, and not easy to take
care of, and people were looking for solutions.
Table 1 Hospital characteristics
Hospital Type Region Affiliated/Onsite Services
Midwest Northeast South West OTP Detox Both Neither
Established AMC Service (n = 9) 3 3 1 2 1 2 2 4
Starting AMC Service (n = 5) 0 1 2 2 1 1 1 2
Total 3 4 3 4 2 3 3 6
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How addiction medicine clinical leaders created these
proposals varied. Two informants explained how the
hospital and other organizations provided administrative
support for business case development. The role of these
business trained professionals was similar at both institu-
tions, to help the clinical champion navigate the adminis-
trative challenges of launching a new hospital program by
managing relationships, garnering the commitment of
internal stakeholders, and organizing logistics:
I was assigned what is called a practice improvement
professional who [had] a Master of Business
Administration … she helped us. We started with lots
and lots of meetings with stakeholders, with lots of
input from people, and lots and lots of workflows, and
tons of bureaucratic nightmares … Her role was
frankly managing the bureaucracy, to get stakeholders
on board and the hospital administration
They [hospital leadership] assigned [us] one of their
[accountable care organization] interns … who helped
us come up with the business case, [she] happened to
be a hospitalist physician herself. That was very
helpful. She was a cheerleader.
The Why
The specific content of the business case varied but
four common elements emerged: 1) describing the in-
creased prevalence of OUD and SUDs in the hospital
or nationally; 2) highlighting the negative impact of
untreated OUD and SUDs on hospital finances; 3)
emphasizing the ongoing care quality and treatment
gap for hospitalized patients with OUD and SUDs;
and 4) noting the success of other institutions with
established AMC service.
Elevated SUD prevalence
Addiction medicine leaders presented local or national
OUD and SUD-related hospital admissions prevalence
data. In one case, addiction medicine leaders used pub-
licly available data:
Fig. 1 Addiction medicine consult service business case template
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It was basically just the Centers for Disease Control
and Prevention data … increased opioid prescribing …
increased fatality … the over dose deaths bypassing
motor vehicle deaths and the newer data showing the
increase in heroin across the country … we had some
specific state data about prevalence of opioid
addiction … so we just showed them the statistical
data. Not stuff we created.
More commonly, addiction medicine champions relied
on internal audits and described these data as compel-
ling to administrators:
An audit of the inpatient [census] at our hospital
3 years ago or so found that 40% of all hospital
admissions had a co-occurring substance use
disorder.
Just the recognition that a lot of the hospitalized
patients—between 30 and 50% of them or more have
some co-occurring substance use problem...
We have such a significant proportion of patients with
substance use disorders. They [hospital leadership]
really felt like it was in line with the goals of the
Fig. 2 Addiction medicine consult service design and operations resource list
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hospital and the mission to have this service available
to the patients.
It is pretty much self-evident. A third or more of ad-
missions to the hospital relate to matters pertaining to
addiction.
We were able to collect data … we presented that to
administration...they didn’t have the awareness of the
saturation of the problem and we were really able to
get buy-in from the president of the university … we
basically just showed them the data...
Negative financial impacts
Another type of data used to narrate the need for the
AMC service was how patients hospitalized with un-
treated SUD increased hospital resource utilization during
admission and the subsequent negative impacts on hos-
pital revenue. Clinical champions noted the importance of
making the argument that the service could directly con-
tribute to decreasing readmission penalties and could de-
crease lengths of stay for this patient population:
From a hospital administration standpoint there was a
lot of interest in reducing length of stay and cost of
care … Many of our patients had very lengthy stays.
What we ended up doing was basically through that
needs assessment building a pretty strong business
case around length of stay reduction and also building
a business case around readmission reductions.
We made a pitch to the chief strategy officer and they
agreed to support the funding … They were starting
at that time to organize and create an accountable
care organization … We had to pitch to them that it
would be good for the accountable care organization
to reduce readmissions at the same time. We also had
to pitch to them that we would be revenue neutral or
better in the fee-for-service system…
At one hospital, administrators were convinced to im-
plement an AMC service because untreated patients
with SUDs had longer admissions and were slowing the
flow of patients from the emergency department to the
inpatient wards. The informant noted that the turning
point for garnering the administrators support occurred
when the emergency department leadership was in-
cluded in making their pitch.
Treatment gap and care quality issues
Addiction medicine champions explained to hospital
leadership that untreated SUD in the hospital was a care
quality issue. One informant described studying and pre-
senting on patient preferences as contributing to AMC
service development:
I led a needs assessment … to better understand the
patient perspective … the key findings were that yes
hospitalization is a reachable moment. We learned
that over two-thirds of people with high risk alcohol
and drug use wanted to cut back or quit and many
wanted medication for addiction to start in the
hospital … From a combination of firsthand
experience and also from doing a fair amount of
legwork talking to different stakeholder groups across
the hospital, it was clear … that we didn’t have the
appropriate resources in place.
Key informants frequently described the undertreat-
ment of SUD as impacting hospital readmission rates:
Then if you looked at the 30-day readmission rate
50% of them had a co-occurring substance use
disorder. There was this recognition and suggestion
that untreated addiction was the driver of hospital
readmission. That was one of the motivations to build
the outpatient service … Rather than sending
someone out with a list of phone numbers to be
actually able to send them somewhere.
One of the things that brought that to their [hospital
administrators] attention was the issue of readmission.
There was a pretty high readmission rate among
patients with SUD diagnoses. And, that under the
current reimbursement system hospitals are penalized
for that amount. So that drew their attention to this
issue.
Success of other institutions
Addiction medicine champions strategically leveraged
the success of other institutions already providing in-
patient resources for SUD treatment to convince admin-
istrators of the value of the service:
In addition to the data that we had collected, it was
honestly some healthy competition. I was saying look
[institution A] has one of these, [institution B] has
one of these, [institution C] has one of these. New
York City is creating a city-wide service through the
health and hospitals program. It is really silly that we
don’t have one. That caught their ear and they were
able to look at the data a little more …
The previous university I worked for had an addiction
medicine fellowship and they closed it down due to
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preference from the administration … We were able
to basically show [our hospital leadership] that we
don’t have this in our state anymore. Our university
could be the driving force for this.
Discussion
Historically, hospital administrators, national hospital as-
sociations, and the Joint Commission have provided lim-
ited attention and resources to the care of hospitalized
patients with addictive disorders, especially those with
OUD. However, in the midst of the opioid-related over-
dose crisis, attention to treatment in the hospital is
growing [30]. National and state policymakers are begin-
ning to address care deficits in this setting. The Centers
for Medicare & Medicaid Services (CMS) now require
the use of the American Society of Addiction Medicine
(ASAM) levels of care for state Medicaid programs
applying for §1115 waivers to redesign SUD delivery
systems [31] and hospitals are a part of this care con-
tinuum [32]. Further, recent legislation in Massachusetts
requires emergency department clinicians to offer and
provide OAT to patients seeking care with an OUD [33].
This is a policy that could be readily extended to care
delivery in the inpatient setting.
Unfortunately, interest in improving hospital care for
patients with OUD and other SUDs, by and large, has
not been driven by ethical, moral, and legal arguments.
Our informants noted that these arguments were not
sufficient for convincing most high-level hospital admin-
istrators to implement an AMC service. Garnering the
support of high-level hospital leadership instead relied
primarily on articulating how the service aligned with
hospital goals and how the service could operate as a fi-
nancially value-maximizing activity; thus, clinical cham-
pions pitched the service as a business proposition. How
this information was gathered and subsequently packaged
for presentation depended on the experience, expertise,
and training of the addiction medicine physicians and
available resources at each hospital.
The prevalence of U.S. AMC services is unknown and
a centralized list or repository of service locations has
yet to be created. There are several U.S. cities, health
systems, hospitals, and academic health centers publicly
promoting and publishing on the existence of their re-
spective AMC services. In New York City, New York
Health and Hospitals launched a city-wide program to
implement six AMC services at six hospitals—the Con-
sult for Addiction Treatment and Care in Hospitals
(CATCH) program. The CATCH program has an evalu-
ation plan in place and will be the first multi-site study
on the effectiveness of AMC services [34]. Other institu-
tions with public-facing programs include: Boston Med-
ical Center [14], Massachusetts General Hospital [16],
Oregon Health & Science University [12, 15, 20, 35, 36],
and the University of Maryland [18].
At least two groups have circulated tools designed to
improve care for patients with OUD and SUDs in the
hospital setting—the California Bridge Program and the
Improving Addiction Care Team (IMPACT) at Oregon
Health & Science University. The California Bridge Pro-
gram, affiliated with the Public Health Institute, provides
open-source resources related to the care of patients with
OUD and SUD in the hospital setting, including but not
limited to: inpatient guidelines, order sets, patient materials,
pharmacy and therapeutics committee materials, and OAT
financing and billing resources [37]. The IMPACT team re-
cently published a compendium of resources including
medication management protocols (e.g., withdrawal proto-
col), assessment tools (e.g., social work SUD assessment),
treatment tools (e.g., patient safety care plan), and other re-
sources (e.g., sample letter to judge or parole officer) [35].
To date, neither group has published tools on how to make
the AMC service business case to hospital administrators;
thus, it is the synthesis of the findings from this study,
paired with prior literature review [22], that informed the
development of two tools to fill this gap: 1) an AMC service
business case template (Fig. 1); and 2) an AMC service de-
sign and operations resource list (Fig. 2).
The purpose of Fig. 1 is to provide evidence and ra-
tionale to convince hospital administrators why an AMC
service would benefit their respective hospital. Figure 1
includes a description of what an AMC service is, why a
service should be created to help address the opioid-
related overdose epidemic, and which organizations are
national leaders of this care delivery intervention. Fig-
ure 2 is a list and summary of recently published re-
sources related to AMC service design and operations to
support clinical champions planning to launch a service.
The primary study limitation is transferability, because
most hospitals in this sample were affiliated with urban
academic health centers and had above average access to
addiction-related resources (e.g., education, staff, re-
search). The findings may be less applicable to hospitals
without addiction medicine experts, addiction medicine
trainees, or that exist in lower-resourced settings. An-
other study limitation was the heterogeneity of the in-
volvement of the study key informants in AMC service
establishment and operations. Differences in positional-
ity, observer versus implementer, may influence the per-
ceptions of the informant [38].
Conclusion
As OUD-related hospitalizations increase, and the drug
poisoning crisis worsens, hospital administrators should
look to innovative care delivery mechanisms to improve
care and outcomes for patients with OUD. The AMC ser-
vice may be a service delivery intervention to achieve these
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aims. For clinical and administrative champions, under-
standing how to communicate the relevance and potential
effectiveness of this organizational intervention, in the
midst of the opioid overdose epidemic, to hospital leaders
is a foundational first step to improving care in this setting
for patients hospitalized with OUD.
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